JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M707629200 on March 4, 2008

J. Biol. Chem., Vol. 283, Issue 19, 13205-13215, May 9, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/19/13205    most recent
M707629200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Wang, Y.
Right arrow Articles by Lee, C. G. L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Y.
Right arrow Articles by Lee, C. G. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Profiling MicroRNA Expression in Hepatocellular Carcinoma Reveals MicroRNA-224 Up-regulation and Apoptosis Inhibitor-5 as a MicroRNA-224-specific Target*Formula

Yu Wang{ddagger}1, Alvin T. C. Lee§1, Joel Z. I. Ma{ddagger}, Jingbo Wang{ddagger}, Jianwei Ren§, Yuchen Yang2, Erwin Tantoso, Kuo-Bin Li3, London L. P. J Ooi||**, Patrick Tan{ddagger}{ddagger}, and Caroline G. L. Lee{ddagger}§{ddagger}{ddagger}4

From the {ddagger}Department of Biochemistry, National University of Singapore, Singapore 119077, Singapore, the §Division of Medical Sciences and ||Department of Surgical Oncology, National Cancer Centre, Singapore 169610, Singapore, the Bioinformatics Institute, Singapore 138671, Singapore, the **Department of Surgery, Singapore General Hospital, Singapore 169608, and the {ddagger}{ddagger}Duke-NUS Graduate Medical School, Singapore 169547, Singapore

Like other cancers, aberrant gene regulation features significantly in hepatocellular carcinoma (HCC). MicroRNAs (miRNAs) were recently found to regulate gene expression at the post-transcriptional/translational levels. The expression profiles of 157 miRNAs were examined in 19 HCC patients, and 19 up-regulated and 3 down-regulated miRNAs were found to be associated with HCC. Putative gene targets of these 22 miRNAs were predicted in silico and were significantly enriched in 34 biological pathways, most of which are frequently dysregulated during carcinogenesis. Further characterization of microRNA-224 (miR-224), the most significantly up-regulated miRNA in HCC patients, revealed that miR-224 increases apoptotic cell death as well as proliferation and targets apoptosis inhibitor-5 (API-5) to inhibit API-5 transcript expression. Significantly, miR-224 expression was found to be inversely correlated with API-5 expression in HCC patients (p < 0.05). Hence, our findings define a true in vivo target of miR-224 and reaffirm the important role of miRNAs in the dysregulation of cellular processes that may ultimately lead to tumorigenesis.


Received for publication, September 11, 2007 , and in revised form, February 5, 2008.

* This work was supported by a National Medical Research Council of Singapore block grant through the National Cancer Centre (to C. G. L.), an individual grant from the National Medical Research Council, and a grant from the BioMedical Research Council (to C. G. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1–S3 and Table S1.

1 These authors contributed equally to this work.

2 Present address: Institute of Molecular and Cell Biology, Singapore.

3 Present address: Bioinformatics Center, National Yang-Ming University, Taipei, 112, Taiwan.

4 To whom correspondence should be addressed: Division of Medical Sciences, National Cancer Center, Level 6, Lab 5, 11 Hospital Dr., Singapore 169610, Singapore. Tel.: 65-6436-8353; Fax: 65-6372-0161; E-mail: bchleec{at}nus.edu.sg.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.